Select Publications
Conference Papers
2008, 'NATURAL HISTORY OF HCV SUPERINFECTION AND REINFECTION', in Hepatology, John Wiley & Sons Inc, Hoboken, NJ, USA, pp. 1056 - 1057, presented at Hepatology
,2008, 'Predictors of HCV incidence in IDU prison inmates', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Carlton, Victoria, Australia, pp. A346 - A347
,2008, 'Preparedness for candidate hepatitis C vaccine trials in people who inject drugs: challenges and opportunities', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Carlton, Victoria, Australia, pp. A358 - A358
,2006, 'Australian trial in acute hepatitis C: preliminary findings', in JOURNAL OF CLINICAL VIROLOGY, ELSEVIER SCIENCE BV, FRANCE, Paris, pp. S139 - S139, presented at 12th International Symposium on Viral Hepatitis and Liver Disease, FRANCE, Paris, 01 July 2006 - 05 July 2006, http://dx.doi.org/10.1016/S1386-6532(06)80430-0
,2006, 'Comprehensive analysis of IFN-gamma and IL-2 production by T cells in acute and chronic HCV infection', in Journal of Clinical Virology, Elsevier Science BV, Amsterdam, Netherlands, pp. S123 - S123, presented at Journal of Clinical Virology, Melbourne
,2003, 'Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution', in BMC health services research, pp. 25
,2002, 'Cellular immunity in people resistant to HCV infection.', in HEPATOLOGY, W B SAUNDERS CO, MASSACHUSETTS, BOSTON, pp. 263A - 263A, presented at 53rd Annual Meeting of the Association-for-the-Study-of-Liver-Diseases (AASLD), MASSACHUSETTS, BOSTON, 01 November 2002 - 05 November 2002, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000178301700383&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2002, 'T lymphocytes, NK and NK-T cells co-expressing the chemokine receptors CXCR3 and CXCR6 are enriched in the HCV infected liver.', in HEPATOLOGY, W B SAUNDERS CO, MASSACHUSETTS, BOSTON, pp. 227A - 227A, presented at 53rd Annual Meeting of the Association-for-the-Study-of-Liver-Diseases (AASLD), MASSACHUSETTS, BOSTON, 01 November 2002 - 05 November 2002, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000178301700244&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2002, 'The effect of distress on the development of a primary immune response.', in PSYCHOSOMATIC MEDICINE, LIPPINCOTT WILLIAMS & WILKINS, pp. 166 - 167, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000173760200384&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2001, 'The balance of pro- and anti-inflammatory cytokines correlates with the outcome of acute experimental Pseudomonas keratitis', in Investigative Ophthalmology and Visual Science, Association of Research Vision Ophthalmology Inc, Rockville, MD, USA, pp. 513 - 513, presented at ARVO 2001: Association for Research in Vision and Ophthalmology, Fort Lauderdale, Florida, 29 April 2001 - 04 May 2001
,1999, 'Gene expression in grafted, liposomally transfected corneas', in INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, ASSOC RESEARCH VISION OPHTHALMOLOGY INC, pp. S250 - S250, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000079269201320&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1999, 'The role of chemokines and their receptors in the regulation of T lymphocyte trafficking to lymph nodes and the outcome of the immune response', in FASEB JOURNAL, FEDERATION AMER SOC EXP BIOL, pp. A658 - A658, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000082132900067&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1997, 'Matrix metalloproteinases and mast cell tryptase in scleritis.', in 4th International Symposium on Uveitis, Yokohama, Japan, pp. 103 - 105, presented at 4th International Symposium on Uveitis, Yokohama, Japan, 01 October 1997
,1997, 'Chemokines in ocular inflammation', in 4th International Symposium on Uveitis, Yokohama, Japan, presented at 4th International Symposium on Uveitis, Yokohama, Japan, 01 October 1997
,1997, 'Metalloproteinases and mast cell tryptase in scleritis', in 4th International Symposium on Uveitis, Yokohama, Japan, presented at 4th International Symposium on Uveitis, Yokohama, Japan, 01 October 1997
,1994, 'Attractive properties of chemokines and their receptors', in International Journal of Immunopathology and Pharmacology, pp. 219 - 220
,1994, 'HUMAN T-LYMPHOCYTE CHEMOTAXIS AND ADHERENCE INDUCED BY VASOACTIVE-INTESTINAL-PEPTIDE', in FASEB JOURNAL, FEDERATION AMER SOC EXP BIOL, pp. A479 - A479, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1994ND19602771&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1994, 'SERUM AMYLOID-A HAS CHEMOATTRACTANT ACTIVITY FOR MONOCYTES AND POLYMORPHONUCLEAR CELLS', in FASEB JOURNAL, FEDERATION AMER SOC EXP BIOL, pp. A234 - A234
,1993, 'IL-8 RECEPTOR EXPRESSION AND REGULATION IN HEMATOPOIETIC-CELLS BY G-CSF AND LPS', in JOURNAL OF IMMUNOLOGY, AMER ASSOC IMMUNOLOGISTS, pp. A126 - A126, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1993KX95600723&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1993, 'ISOLATION AND CHARACTERIZATION OF IL-8 TYPE-I AND TYPE-II RECEPTOR GENES', in JOURNAL OF IMMUNOLOGY, AMER ASSOC IMMUNOLOGISTS, pp. A126 - A126, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1993KX95600720&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1993, 'PREFERENTIAL CHEMOTAXIS AND ADHESION OF T-CELL SUBSETS IN RESPONSE TO MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA (MIP-1-ALPHA), MIP-1-BETA, AND RANTES', in JOURNAL OF IMMUNOLOGY, AMER ASSOC IMMUNOLOGISTS, pp. A46 - A46, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1993KX95600257&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1993, 'Biochemical correlates of in vivo cell-mediated immune dysfunction in patients with depression - a preliminary report', in International Journal of Immunopharmocology, Elsevier Science, UK, presented at Psychoimmune networks on Health and Disease, Sydney, 01 April 1993 - 03 April 1993
,1993, 'Cell-mediated function and the outcome of chronic fatigue syndrome', in International Journal of Immunopharmocology, Elsevier Science, UK, presented at Psychoimmune networks on Health and Disease, Sydney, 01 April 1993 - 03 April 1993
,1993, 'Delayed-type hypersensitivity skin testing - normal values in the Australian population (17)', in International Journal of Immunopharmocology, Elsevier Science, UK, presented at Psychoimmune networks on Health and Disease, Sydney, 01 April 1993 - 03 April 1993
,1993, 'REGULATION OF T-CELL SUBSET ADHESION BY CHEMOKINE FAMILY MEMBERS', in JOURNAL OF CELLULAR BIOCHEMISTRY, WILEY-LISS, pp. 92 - 92, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1993KN46500332&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1993, 'CYTOKINE PRODUCTION IN PATIENTS WITH CHRONIC FATIGUE SYNDROME', in JOURNAL OF LEUKOCYTE BIOLOGY, FEDERATION AMER SOC EXP BIOL, pp. 54 - 54, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1993ME18500123&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1993, 'Cytokines and cytokine receptors in health and disease. A summary of the National Heart, Lung and Blood Institute Frontiers in Basic Sciences Symposium, December 2-3, 1992', in Cytokine, pp. 399 - 406, http://dx.doi.org/10.1016/1043-4666(93)90029-5
,1993, 'FUNCTIONAL AND PROMISCUOUS CHEMOKINE RECEPTORS ENCODED BY HUMAN CYTOMEGALOVIRUS', in JOURNAL OF LEUKOCYTE BIOLOGY, FEDERATION AMER SOC EXP BIOL, pp. 131 - 131, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1993ME18500586&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1993, 'IL-8 RECEPTOR REGULATION IN POLYMORPHONUCLEAR LEUKOCYTES BY G-CSF AND LPS', in JOURNAL OF LEUKOCYTE BIOLOGY, FEDERATION AMER SOC EXP BIOL, pp. 48 - 48, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1993ME18500087&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1993, 'The effects of human recombinant MIP-1α, MIP-1β, and rantes on the chemotaxis and adhesion of T cell subsets', in Advances in Experimental Medicine and Biology, pp. 139 - 146, http://dx.doi.org/10.1007/978-1-4615-2952-1_15
,1991, 'ROLE OF INFLAMMATORY CYTOKINES IN ALLERGY', in Miyamoto T; Okuda M (ed.), PROGRESS IN ALLERGY AND CLINICAL IMMUNOLOGY, VOL 2, KYOTO, HOGREFE & HUBER PUBLISHERS, JAPAN, KYOTO, pp. 445 - 450, presented at 14TH INTERNATIONAL CONGRESS OF ALLERGOLOGY AND CLINICAL IMMUNOLOGY, JAPAN, KYOTO, 13 October 1991 - 18 October 1991, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1992BX58P00080&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1990, 'Muscle versus brain: Chronic fatigue syndrome', in Medical Journal of Australia, pp. 530 - 534, http://dx.doi.org/10.5694/j.1326-5377.1990.tb126193.x
,Conference Posters
2018, 'Ongoing incident hepatitic c virus infection among people with a history of injecting drug use in an Australian prison setting', Vol. 1, pp. 278 - 280, http://dx.doi.org/10.1093/JCAG/GWY008.162
,Conference Presentations
2022, 'The role of point-of-care hepatitis C RNA testing at prison intake for reducing barriers to the hepatitis C care cascade', presented at Australasian Viral Hepatitis Conference, Brisbane, 29 May 2022 - 31 May 2022
,2021, 'Perceptions and concerns of hepatitis c reinfection in the prison setting', presented at Justice Health Conference, Public Health Association Australia, Virtual (Australia), 03 November 2021 - 04 November 2021
,2021, 'Correctional Officers and Health Staff Perspectives Of Hepatitis C Treatment As Prevention Scale Up Within The Prison Setting', presented at International Conference on Health and Hepatitis in Substance Users (INHSU), Virtual (International), 13 October 2021 - 15 October 2021
,2021, 'Scaling Up Hepatitis C Treatment within the Prison Setting: The Role of Social Capital', presented at Academic and Health Policy Conference on Correctional Health (ACCJH), Virtual (USA), 08 April 2021 - 10 April 2021
,2021, 'Optimised approach for high throughput hepatitis C virus amplification for transmission cluster identification in Australian prisons', presented at 16th National Scientific Workshop of the Australian Center for HIV and Hepatitis Virology Research, Bowral, Australia
,2020, 'Resolving within-host, full length, dengue virus variants without haplotype reconstruction using Oxford Nanopore Technology', presented at ECCMID 2020, Paris, France
,2019, 'A single nested PCR method for full length dengue virus genome amplification', presented at 7th European Congress of Virology, Rotterdam, The Netherlands
,2019, 'Using networks to study epistatic interactions of HCV', presented at 14th Scientific Workship of the Australian Center for HIV and Hepatitis Virology Research, Canungra, Australia
,2019, 'Whole genome long read sequencing of Hepatitis C virus and its applications', presented at 14th National Scientific Workshop of the Australian Center for HIV and Hepatitis Virology Research, Canungra, Australia
,2018, 'Challenges in characterizing hepatitis C virus founder variants with deep sequencing', presented at 13th National Scientific Workshop of the Australian Center for HIV and Hepatitis Virology Research
,2018, 'Genetic variability of Hepatitis C quasi-species in early infection', presented at Global Hepatitis Summit, Toronto, Canada
,2018, 'Host IFNλ3 genotype and viral genotype are key determinants of within-host HCV genomic variation in early infection', presented at 13th National Scientific Workshop of the Australian Center for HIV and Hepatitis Virology Research, Yarra Valley, Australia
,2017, 'A framework for hepatitis C virus treatment as prevention in the prison setting: the SToP-C implementation toolkit', presented at International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, NETHERLANDS, Amsterdam, 19 April 2017 - 23 April 2017, http://dx.doi.org/10.1016/S0168-8278(17)31387-9
,2017, 'Establishment of InC3 viral sequence repository and its applications', presented at 12th National Scientific Workshop of the Australian Center for HIV and Hepatitis Virology Research, Barossa Valley, Australia
,2016, 'Bayesian evolutionary analysis of hepatitis C epidemic in Australia and North America in 20th century', presented at Australasian Viral Hepatitis Conference, GoldCoast, Australia
,2016, 'Bayesian evolutionary analysis of hepatitis C epidemic in Australia and North America in 20th century', presented at International conference in Systems Biology, Barcelona, Spain
,2016, 'Broadly neutralizing antibodies against hepatitis C envelope; using a network approach to understand co-evolution of critical residues', presented at International conference in Systems Biology, Barcelona, Spain
,